Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J9353. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
26
Median % of Medicare
--
Rate range
$2.74 - $56.44
J9353 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $2.74 | -- | -- | 2026 |
| California | $53.27 | -- | -- | 2026 |
| Connecticut | $53.75 | -- | -- | 2026 |
| District of Columbia | $53.75 | -- | Required | 2026 |
| Idaho | $46.44 | -- | Required | 2026 |
| Illinois | $51.83 | -- | -- | 2026 |
| Indiana | $54.51 | -- | -- | 2025 |
| Kansas | $56.44 | -- | -- | 2026 |
| Kentucky | $53.75 | -- | -- | 2026 |
| Louisiana | $49.40 | -- | -- | 2026 |
| Maine | $56.44 | -- | -- | 2026 |
| Michigan | $56.44 | -- | -- | 2026 |
| Mississippi | $53.75 | -- | -- | 2026 |
| Montana | $53.75 | -- | -- | 2026 |
| Nebraska | $56.44 | -- | -- | 2026 |
| New Jersey | $41.12 | -- | Not required | 2026 |
| New Mexico | $49.40 | -- | -- | 2025 |
| Oklahoma | $56.44 | -- | -- | 2026 |
| Rhode Island | $51.85 | -- | -- | 2026 |
| South Carolina | $56.44 | -- | -- | 2026 |
| Texas | $50.45* | -- | -- | 2026 |
| Utah | $56.44* | -- | Not required | 2026 |
| Virginia | $56.44 | -- | -- | 2026 |
| Vermont | $49.87 | -- | Required | 2026 |
| Washington | $56.44 | -- | -- | 2026 |
| Wisconsin | $56.44 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 198 codes from J9000 to J9601 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J9353?
26 state Medicaid programs publish a fee-for-service rate for J9353 (injection, margetuximab-cmkb, 5 mg), ranging from $2.74 in Arkansas to $56.44 in Kansas. The full table on this page lists every publishing state's current rate.
Which state pays the most for J9353?
Kansas publishes the highest Medicaid rate for J9353 at $56.44. Arkansas publishes the lowest at $2.74.
Does J9353 require prior authorization under Medicaid?
3 of the 26 publishing states flag J9353 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".